首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate.
【24h】

Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate.

机译:抑制NMDA诱导的纹状体多巴胺的释放和神经活性类固醇3alpha-羟基-5beta-pregnan-20-半琥珀酸酯的行为激活。

获取原文
获取原文并翻译 | 示例
           

摘要

Our laboratory has previously shown that the synthetic neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate (3alpha5betaHS) is a negative modulator of NMDA receptors in vitro. Similarly, 3alpha5betaHS exhibits rapid sedative, analgesic, anticonvulsive, and neuroprotective effects in vivo. Here we report a study designed to investigate whether a negatively charged neuroactive steroid, 3alpha5betaHS, modulates the action of NMDA receptors in vivo. Our results indicate that peripherally administered 3alpha5betaHS enters the CNS and inhibits NMDA-mediated motor activity and dopamine release in the rat striatum. The increase in motor activity induced by intrastriatal microinjection of NMDA was blocked by the systemic administration of 3alpha5betaHS and the NMDA-induced increase in extracellular dopamine in the striatum was also attenuated by both systemically administered and intrastriatally administered (by in vivo microdialysis) 3alpha5betaHS. These data indicate that 3alpha5betaHS acts through striatal NMDA receptors in vivo. When taken together, these results suggest that neuroactive steroids may prove to be effective in the treatment of neurological and psychiatric disorders involving over-stimulation of NMDA receptors in the mesotelencephalic dopamine system.
机译:我们的实验室以前已经表明,合成的神经活性类固醇3alpha-羟基-5beta-pregnan-20-一丁二酸酯(3alpha5betaHS)在体外是NMDA受体的负调节剂。同样,3alpha5betaHS在体内表现出快速的镇静,镇痛,抗惊厥和神经保护作用。在这里,我们报告了一项旨在调查带负电荷的神经活性类固醇3alpha5betaHS是否在体内调节NMDA受体作用的研究。我们的结果表明,外围给药的3alpha5betaHS进入中枢神经系统并抑制NMDA介导的运动活性和大鼠纹状体中的多巴胺释放。全身给药3alpha5betaHS可阻止由纹状体内注射NMDA诱导的运动活动的增加,并且全身给药和纹状体内给药(通过体内微透析)3alpha5betaHS均可抑制NMDA诱导的纹状体中细胞外多巴胺的增加。这些数据表明3alpha5betaHS在体内通过纹状体NMDA受体起作用。综合起来,这些结果表明,神经活性类固醇可能被证明可有效治疗中脑多巴胺系统中过度刺激NMDA受体的神经和精神疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号